Skip to main content
Clinical Trials/NCT06488690
NCT06488690CompletedNot Applicable

Effectiveness of Early Warning Scores: Preoperative Period in Pregnant Women

Suleyman Demirel University1 site in 1 country304 target enrollmentStarted: April 1, 2022Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
304
Locations
1
Primary Endpoint
MEWT score

Study Overview

Brief Summary

Our study aims to evaluate the use of early warning scores as a screening tool to predict obstetric mortality and morbidity in pregnant women who will undergo cesarean section.

Detailed Description

Our study aims to evaluate the use of early warning scores as a screening tool to predict obstetric mortality and morbidity in pregnant women who will undergo cesarean section.

This prospective study included 304 patients undergoing cesarean section at Suleyman Demirel University between April 2022 and April 2023. Physiological parameters were assessed in all 304 pregnant women before the operation. Maternal early warning scores, including modified early obstetric warning score (MEOWS), maternal early warning score (MEWC), and maternal early warning triggers (MEWT), were calculated for each patient. Patients triggering the system were classified as Group 1 (risky patients), while those not triggering the system were classified as Group 2 (risk-free patients).

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Sequential
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •All patients who are pregnant and undergo cesarean section

Exclusion Criteria

  • Not provided

Arms & Interventions

All patients who are pregnant and undergo cesarean section

Other

We included all patients who were pregnant and underwent cesarean section and calculated maternal early warning scores.

Intervention: All patients who were pregnant and underwent cesarean section (Other)

Outcomes

Primary Outcomes

MEWT score

Time Frame: One year

For MEWT, the presence of a "trigger" defined as either a single severely abnormal parameter (falling in the "red" zone) or two mildly abnormal parameters (falling in the "yellow" zone) was categorized as the risky group, with the absence or mildness of the trigger considered as the risk-free group.

MEOWS, MEWC and MEWT scores

Time Frame: One year

The presence of a "trigger" for MEOWS in all systems, defined as either a single severely abnormal parameter (falling in the "red" zone) or two slightly abnormal parameters (falling in the "yellow" zone), was categorized as the risky group. Absence or mildness of the trigger was considered as the risk-free group.

MEWC score

Time Frame: One year

In the case of MEWC, the presence of only one abnormal parameter designated the risk group, while the absence of a trigger indicated the risk-free group.

Secondary Outcomes

  • Aldrete score(One year)
  • APGAR score(One year)
  • Glasgow Coma Scale(One year)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Onurcan BALIK

Doctor

Suleyman Demirel University

Study Sites (1)

Loading locations...

Similar Trials